Your Guide to Financial Freedom
AXT, Inc. (NASDAQ:AXTI), a key player in semiconductor materials, recently received a renewed vote of confidence from financial analyst firm Northland. On June 25, Northland reiterated its coveted “Outperform” rating for AXTI, maintaining an impressive $125 price target. This endorsement follows a “very positive” presentation by AXT, Inc. at Northland’s NCM Growth Conference, leading analysts … Read more
Domino’s Pizza Inc (NYSE:DPZ) faces a challenging second quarter, with UBS forecasting weaker-than-expected US same-store sales. Macroeconomic pressures, intense promotional activity across the pizza sector, and difficult prior-year comparisons are identified as primary culprits impacting performance. Economic Headwinds Impacting Domestic Performance UBS projects a 1.5% decline in Domino’s US same-store sales for Q2, a stark … Read more
Exelixis (EXEL) Oncology Pipeline: A Closer Look at Clinical Performance Exelixis, Inc. (NASDAQ:EXEL), a prominent oncology biopharmaceutical company, navigates a complex landscape of drug development and regulatory milestones. The company’s recent disclosure on June 22 regarding its Phase 3 STELLAR 303 data has garnered investor attention, offering insights into its therapeutic candidates for metastatic colorectal … Read more
Bank of America (BofA) has adjusted its price target for Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), reducing it from $550 to $542. The firm has, however, maintained a Neutral rating on the biopharmaceutical company’s stock, signaling a cautious but not overtly pessimistic outlook. This revision primarily stems from an evolving perception of the market for Rezdiffra, Madrigal’s … Read more
IREN Limited (NASDAQ:IREN), recognized as a promising, often overlooked stock, has made headlines with a substantial executive compensation announcement. On July 2, Forbes reported that the company’s board sanctioned a four-year equity package valued at an impressive US$788 million for its co-founders and co-CEOs, Will Roberts and Daniel Roberts. This significant payout comprises over 9 … Read more
Axsome Therapeutics (AXSM) Emerges as ‘Under-the-Radar’ Investment Leader Axsome Therapeutics, Inc. (NASDAQ:AXSM), a commercial-stage biopharmaceutical company, has recently captured significant market attention, cementing its position as one of the standout “under-the-radar” stocks for astute investors. The company specializes in developing innovative therapies tailored for managing central nervous system (CNS) disorders, a field with substantial unmet … Read more
Meta Platforms (NASDAQ: META), despite a challenging year with stock declining nearly 7% in 2026, has ignited fresh investor interest with a strategic shift into the lucrative cloud computing market. The announcement, reported by Bloomberg on July 1, propelled Meta’s stock up 8.6% the following trading day. This move signifies a significant broadening of Meta’s … Read more
Global energy markets witnessed significant upheaval on Wednesday as crude oil and gasoline prices surged, driven primarily by escalating geopolitical tensions in the Middle East. August WTI crude oil (CLQ26) climbed +3.08, marking a +4.37% increase, while August RBOB gasoline (RBQ26) rose by +0.1495, or +5.06%. This sharp ascent propelled crude to a 2-week high … Read more
Alibaba (BABA) shares experienced a significant uplift following a recent corporate update. This briefing highlighted robust growth in Artificial Intelligence (AI) initiatives and clear signs of improving operational efficiency across its diverse business segments. The positive momentum was strong enough to push BABA stock above its crucial 20-day moving average (MA), a key technical indicator … Read more
August Nymex natural gas (NGQ26) prices experienced a notable downturn on Wednesday, closing down -0.053 (-1.62%). This decline followed an earlier rally that saw prices reach a 1.5-week high, only to be erased by the looming prospect of a significant increase in U.S. domestic natural gas stockpiles. The prevailing market consensus points to a larger-than-normal … Read more